Skip to main content

Table 1 Bloodstream infection (BSI) episodes in three time periods

From: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study

 

Total

2002–2005

2006–2009

2010–2013

All BSIs

1995 (100,0)

582 (100.0)

638 (100.0)

775 (100.0)

Place of acquisition

 Community acquired

934 (46.8)

317 (54.5)

280 (43.9)

337 (43.5)

 Health care-associated

787 (39.4)

175 (30.1)

277 (43.4)

335 (43.2)

 Hospital acquired

274 (13.7)

90 (15.5)

81 (12.7)

103 (13.3)

Microbial agent(s)

Escherichia coli

686 (34.4)

186 (32.0)

231 (36.2)

269 (34.7)

Streptococcus pneumoniae

225 (11.3)

80 (13.8)

80 (12.5)

65 (8.4)

Staphylococcus aureus

218 (10.9)

72 (12.4)

55 (8.6)

91 (11.7)

Klebsiella spp.

135 (6.8)

22 (3.8)

44 (6.9)

69 (8.9)

 Beta-hemolytic streptococci

104 (5.2)

33 (5.7)

35 (5.5)

36 (4.6)

Enterococcus spp.

89 (4.5)

28 (4.8)

26 (4.1)

35 (4.5)

 Other mixed bacterial infections

68 (3.4)

21 (3.6)

19 (3.0)

28 (3.6)

Pseudomonas spp.

58 (2.9)

20 (3.4)

21 (3.3)

17 (2.2)

 Viridans group streptococci

57 (2.9)

15 (2.6)

19 (3.0)

23 (3.0)

 Coagulase-negative staphylococci

54 (2.7)

23 (4.0)

11 (1.7)

20 (2.6)

Proteus spp.

48 (2.4)

17 (2.9)

15 (2.3)

16 (2.1)

 Anaerobic Gram-negative bacteria

45 (2.3)

14 (2.4)

16 (2.5)

15 (1.9)

 Mixed Gram-negative aerobic or anaerobic bacteria

42 (2.1)

13 (2.2)

11 (1.7)

18 (2.3)

 Enterobacter spp.

37 (1.9)

8 (1.4)

14 (2.2)

15 (1.9)

 Other Enterobacteriaceae

37 (1.9)

7 (1.2)

12 (1.9)

18 (2.3)

 Other aerobic Gram-negative bacteria

19 (1.0)

5 (0.9)

4 (0.6)

10 (1.3)

Haemophilus influenzae

17 (0.9)

6 (1.0)

8 (1.3)

3 (0.4)

Candida spp.

14 (0.7)

1 (0.2)

4 (0.6)

9 (1.3)

 Anaerobic Gram-positive bacteria

11 (0.6)

3 (0.5)

4 (0.6)

4 (0.5)

 Mixed gram-positive aerobic or anaerobic bacteria

11 (0.6)

1 (0.2)

4 (0.6)

6 (0.8)

Neisseria meningitidis

9 (0.5)

4 (0.7)

2 (0.3)

3 (0.4)

Listeria monocytogenes

8 (0.4)

2 (0.3)

2 (0.3)

4 (0.5)

 Mixed bacterial and fungal infections

3 (0.2)

1 (0.2)

1 (0.2)

1 (0.1)

  1. The table shows number (percent) of BSIs overall, by place of acquisition, and by microbial agent(s)